This federal contract award, valued at $5,514.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product, with a period of performance ending on April 29, 2024.
Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) worldwide. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen, a subsidiary of the larger Cencora, Inc. parent company, has demonstrated its expertise in pharmaceutical distribution and its ability to efficiently supply critical medical products to various government agencies, including the DoD and the VA healthcare system.
Generated 7/26/24, 9:24 AM